Evidence map›Paper›PMID 37186513›Full record

ArticleClinical and translational medicine2023

Detection of pathogens and antimicrobial resistance genes directly from urine samples in patients suspected of urinary tract infection by metagenomics nanopore sequencing: A large-scale multi-centre study.

Manjiao Liu, Simin Yang, Susheng Wu, Li Chen, Shan Li, Zhenzhong Li, Mingzhe Zhou, Lili Wang, Hui Xu, Ryon Liu and 8 more

Open access · goldAbstract readMulticenter StudyLetter
In one paragraph

Article in Clinical and translational medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 1 country.

Manjiao LiuState Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd., Nanjing, P. R. China.
Simin YangDepartment of Laboratory Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, P. R. China.
Susheng WuState Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd., Nanjing, P. R. China.
Li ChenState Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd., Nanjing, P. R. China.
Shan LiState Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd., Nanjing, P. R. China.
Zhenzhong LiState Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd., Nanjing, P. R. China.
Mingzhe ZhouState Key Laboratory of Genetic Engineering, School of Life Science, Fudan University, Shanghai, P. R. China.
Lili WangDepartment of Laboratory Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, P. R. China.
Hui XuState Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd., Nanjing, P. R. China.
Ryon LiuState Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd., Nanjing, P. R. China.
Yi FangDepartment of Laboratory Medicine, Huadong Hospital, Fudan University, Shanghai, P. R. China.
Weichun HuangDepartment of Laboratory Medicine, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China.
Min ZhangDepartment of Laboratory Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, P. R. China.
Wenzheng GuoDepartment of Laboratory Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, P. R. China.
Yan DaiState Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd., Nanjing, P. R. China.
Yong RenState Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd., Nanjing, P. R. China.
Hao GuoState Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd., Nanjing, P. R. China.
Wenjuan WuDepartment of Laboratory Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, P. R. China.
Simcere Pharmaceutical (China) · CNShanghai East Hospital · CNFudan University · CNHuadong Hospital · CNShanghai Children's Medical Center · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Infective AgentsNanopore SequencingUrinary Tract InfectionsAnti-Bacterial AgentsDrug Resistance, BacterialHumansMetagenomicsAnti-Bacterial AgentsAnti-Infective Agents

Identifiers

PMID37186513
PMCPMC10131482
OpenAlexW4367056685

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.